These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 2843004)
1. 1 alpha,25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes. Provvedini DM; Rulot CM; Sobol RE; Tsoukas CD; Manolagas SC J Bone Miner Res; 1987 Jun; 2(3):239-47. PubMed ID: 2843004 [TBL] [Abstract][Full Text] [Related]
2. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606 [TBL] [Abstract][Full Text] [Related]
3. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959 [TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes. Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395 [TBL] [Abstract][Full Text] [Related]
5. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. Koren R; Ravid A; Liberman UA; Hochberg Z; Weisman Y; Novogrodsky A J Clin Invest; 1985 Nov; 76(5):2012-5. PubMed ID: 2997300 [TBL] [Abstract][Full Text] [Related]
6. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Koga M; Eisman JA; Sutherland RL Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048 [TBL] [Abstract][Full Text] [Related]
7. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648 [TBL] [Abstract][Full Text] [Related]
8. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Dokoh S; Donaldson CA; Haussler MR Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995 [TBL] [Abstract][Full Text] [Related]
9. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration. Thomas GA; Simpson RU Cancer Biochem Biophys; 1986 Jul; 8(3):221-34. PubMed ID: 3017543 [TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. Manolagas SC; Werntz DA; Tsoukas CD; Provvedini DM; Vaughan JH J Lab Clin Med; 1986 Dec; 108(6):596-600. PubMed ID: 3023512 [TBL] [Abstract][Full Text] [Related]
11. No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. Merke J; Klaus G; Hügel U; Waldherr R; Ritz E J Clin Invest; 1986 Jan; 77(1):312-4. PubMed ID: 3003152 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D affects proliferation of a murine T helper cell clone. Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect by 1,25-dihydroxyvitamin D3 on concanavalin A-stimulated proliferation of rat thymic lymphocytes. Kojima A; Hato F; Kinoshita Y; Nishizawa Y; Morii H Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):867-75. PubMed ID: 1477603 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation. Sato M; Hiragun A J Cell Physiol; 1988 Jun; 135(3):545-50. PubMed ID: 2840436 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor. Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380 [TBL] [Abstract][Full Text] [Related]
16. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. Provvedini DM; Manolagas SC J Clin Endocrinol Metab; 1989 Apr; 68(4):774-9. PubMed ID: 2564005 [TBL] [Abstract][Full Text] [Related]
17. Systematic search for 1 alpha,25-dihydroxy-vitamin D3 receptors in human breast carcinomas. Ulmann A; Brami M; Corcos D; Bader C; Delarue JC; Contesso G Biomed Pharmacother; 1984; 38(4):204-8. PubMed ID: 6093907 [TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue. Trydal T; Bakke A; Aksnes L; Aarskog D Cancer Res; 1988 May; 48(9):2458-61. PubMed ID: 2833346 [TBL] [Abstract][Full Text] [Related]
19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW; Sergeev IN; Bishop JE; Okamura WH Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333 [TBL] [Abstract][Full Text] [Related]